Work

Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non–Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients

Year: 2020

Type: article

Study design: Observational Study

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2020.01.009

Authors: Ravi Rajaram, Arlene M. Correa, Ting Xu, Quynh-Nhu Nguyen, Mara B. Antonoff, David Rice, Reza Mehran, Jack Roth, Garrett Walsh, Stephen Swisher, Wayne L. Hofstetter, Ara Vaporciyan, Tina Cascone, Anne S. Tsao, Vassiliki A. Papadimitrakopoulou, Saumil Gandhi, Zhongxing Liao, Boris Sepesi

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, Merck, Novartis, Roche, Ariad Pharmaceuticals, F. Hoffmann-La Roche, Seattle Genetics, Clovis Oncology, Incyte, MedImmune, Genentech, University of Texas MD Anderson Cancer Center, Janssen Biotech

OpenAlex ID: W3004353777

FWCI: 1.238

Cites: 27

Cited by: 16

Related to: 10